LYMRIT 37-01: A Phase I/II Study of 177lu-Lilotomab Satetraxetan (Betalutin®) Antibody-Radionuclide-Conjugate (ARC) for the Treatment of Relapsed Non-Hodgkin's Lymphoma (NHL) — Ana... von Kolstad, Arne, Madsbu, Ulf, Beasley, Matthew, Bayne, Michael, Illidge, Tim M., O'Rourke, Noelle, Lagerlöf, Ingemar, Hajek, Roman, Jurczak, Wojciech, Willenbacher, Ella, Fagerli, Unn Merete, Obr, Aleš, Blakkisrud, Johan, Muftuler Løndalen, Ayca, Rojkjaer, Lisa, Østengen, Åse, Bolstad, Nils, Spetalen, Signe, Erlanson, Martin, Galleberg, Renate, Nygaard Rudå, Stine, Holte, Harald

Volltext

177 Lu-Lilotomab Satetraxetan, a Novel CD37-Targeted Antibody-Radionuclide Conjugate in Relapsed Non-Hodgkin's Lymphoma (NHL): Updated Results of an Ongoing Phase I/II Study (LYMRI... von Kolstad, Arne, Madsbu, Ulf, Beasley, Matthew, Bayne, Michael, Illidge, Tim M., O'Rourke, Noelle, Lagerlöf, Ingemar, Hájek, Roman, Jurczak, Wojciech, Willenbacher, Ella, Blakkisrud, Johan, Muftuler Løndalen, Ayca, Rojkjaer, Lisa, Baylor Curtis, Laurie, Bloma, Marianne, Turner, Simon, Bolstad, Nils, Spetalen, Signe, Erlanson, Martin, Fagerli, Unn Merete, Galleberg, Renate, Nygaard Rudå, Stine, Holte, Harald

Volltext

Efficacy and Safety Results of a Phase 1 Study of 177 lu-DOTA-HH1 (Betalutin®) with and without HH1 Pre-Dosing for Patients with Relapsed CD37+ Non-Hodgkin B Cell Lymphoma (NHL) von Kolstad, Arne, Madsbu, Ulf, Bolstad, Bjørg, Stokke, Caroline, Bach-Gansmo, Tore, Muftuler Løndalen, Ayca, Holtedahl, Jon Erik, Revheim, Mona Elisabeth, Bruland, Øyvind, Dahle, Jostein, Bolstad, Nils, Hartvig Larsen, Roy, Spetalen, Signe, Erlanson, Martin, Nygaard Rudå, Stine, Holte, Harald

Volltext

177lu-Satetraxetan-Lilotomab in the Treatment of Patients with Indolent Non-Hodgkin B-Cell Lymphoma (NHL), Phase 1/2 Safety and Efficacy Data from Four Different Pre-Dosing Regimen... von Kolstad, Arne, Madsbu, Ulf, Beasley, Matthew, Bayne, Michael, Illidge, Tim, O'Rourke, Noelle, Stokke, Caroline, Bach-Gansmo, Tore, Løndalen, Ayca Muftuler, Holtedahl, Jon Erik, Revheim, Mona Elisabeth, Bruland, Øyvind, Dahle, Jostein, Baylor Curtis, Laurie, Østengen, Åse, Turner, Simon, Bolstad, Nils, Hartvig Larsen, Roy, Spetalen, Signe, Erlanson, Martin, Nygaard Rudå, Stine, Holte, Harald

Volltext

Abstract LB-252: Efficacy and safety results of Betalutin® (177Lu-DOTA-HH1) in a phase I/II study of patients with non-hodgkin B-cell lymphoma (NHL) von Kolstad, Arne, Madsbu, Ulf, Beasley, Matthew, Bayne, Michael, Stokke, Caroline, Bach-Gansmo, Tore, Løndalen, Ayca Muftuler, Holtedahl, Jon Erik, Revheim, Mona Elisabeth, Bruland, Øyvind, Dahle, Jostein, Curtis, Laurie Baylor, Østengen, Åse, Turner, Simon, Bolstad, Nils, Larsen, Roy H., Spetalen, Signe, Erlanson, Martin, Rudå, Stine Nygaard, Holte, Harald

Volltext

A Phase I Study of 177 lu-DOTA-HH1 (Betalutin) Radioimmunotherapy for Patients with Relapsed CD37+ Non-Hodgkin’s B Cell Lymphoma von Kolstad, Arne, Madsbu, Ulf, Dahle, Jostein, Stokke, Caroline, Bach-Gansmo, Tore, Muftuler Løndalen, Ayca, Holtedahl, Jon Erik, Revheim, Mona Elisabeth, Bruland, Øyvind, Bolstad, Bjørg, Bolstad, Nils, Tierens, Anne, Larsen, Roy Hartvig, Alfheim, Jan Alan, Delabie, Jan, Signe, Spetalen, Erlanson, Martin, Nygaard Rudå, Stine, Holte, Harald

Volltext

A Phase I Study of (177)lu-DOTA-HH1 (Betalutin) Radioimmunotherapy for Patients with Relapsed CD37+Non-Hodgkin's B Cell Lymphoma von Kolstad, Arne, Madsbu, Ulf, Dahle, Jostein, Stokke, Caroline, Bach-Gansmo, Tore, Londalen, Ayca Muftuler, Holtedahl, Jon Erik, Revheim, Mona Elisabeth, Bruland, Oyvind, Bolstad, Bjorg, Bolstad, Nils, Tierens, Anne, Larsen, Roy Hartvig, Alfheim, Jan Alan, Delabie, Jan, Signe, Spetalen, Erlanson, Martin, Ruda, Stine Nygaard, Holte, Harald

Volltext